Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 43

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis

Cero, Cheryl, Razzoli, Maria, Han, Ruijun, Sahu, Bhavani Shankar, Patricelli, Jessica, Guo, ZengKui, Zaidman, Nathan A., Miles, John M., O'Grady, Scott M., Bartolomucci, Alessandro · 2017 · Molecular Metabolism

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmet.2016.10.005

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 63

  1. Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 · DOI · Paper page
  2. Kopelman, 2000, Obesity as a medical problem, Nature, 404, 635, 10.1038/35007508 · DOI · Paper page
  3. Lönnqvist, 1992, Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells, Journal of Clinical Investigation, 90, 2175, 10.1172/JCI116103 · DOI
  4. Large, 1999, Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects, Journal of Lipid Research, 40, 2059, 10.1016/S0022-2275(20)32429-9 · DOI · Paper page
  5. Mowers, 2013, Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1, Elife, 2, e01119, 10.7554/eLife.01119 · DOI
  6. Arner, 2014, Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance, Trends in Endocrinology & Metabolism, 25, 255, 10.1016/j.tem.2014.03.002 · DOI · Paper page
  7. Coleman, 2011, Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling, Chemical Reviews, 111, 6359, 10.1021/cr100404w · DOI · Paper page
  8. Morigny, 2016, Adipocyte lipolysis and insulin resistance, Biochimie, 125, 259, 10.1016/j.biochi.2015.10.024 · DOI · Paper page
  9. Mottillo, 2007, Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue, American Journal of Physiology – Endocrinology and Metabolism, 293, E1188, 10.1152/ajpendo.00051.2007 · DOI
  10. Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proceedings of the National Academy of Sciences of the United States of America, 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
  11. Possenti, 2012, Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21, Biochemical Journal, 441, 511, 10.1042/BJ20111165 · doi:10.1042/bj20111165
  12. Cero, 2014, The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism, Structure, 22, 1744, 10.1016/j.str.2014.10.001 · doi:10.1016/j.str.2014.10.001
  13. Hannedouche, 2013, Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells, Journal of Biological Chemistry, 288, 27434, 10.1074/jbc.M113.497214 · DOI
  14. Fairbanks, 2014, The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity, Pain, 155, 1229, 10.1016/j.pain.2014.03.012 · DOI
  15. Stephens, 2012, A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function, Cell Metabolism, 16, 33, 10.1016/j.cmet.2012.05.011 · doi:10.1016/j.cmet.2012.05.011
  16. Fargali, 2014, The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure, FASEB Journal, 28, 2120, 10.1096/fj.13-239509 · doi:10.1096/fj.13-239509
  17. D'Amato, 2015, VGF peptide profiles in type 2 diabetic patients' plasma and in obese mice, PLoS One, 10, e0142333, 10.1371/journal.pone.0142333 · DOI
  18. Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI · Paper page
  19. Bachman, 2002, betaAR signaling required for diet-induced thermogenesis and obesity resistance, Science, 297, 843, 10.1126/science.1073160 · DOI · Paper page
  20. Tschöp, 2011, A guide to analysis of mouse energy metabolism, Nature Methods, 9, 57, 10.1038/nmeth.1806 · DOI · Paper page
  21. Razzoli, 2015, Stress-induced activation of brown adipose tissue prevents obesity in conditions of low adaptive thermogenesis, Molecular Metabolism, 5, 19, 10.1016/j.molmet.2015.10.005 · DOI
  22. Pollesello, 1993, 1H NMR spectroscopic studies of lipid extracts from human fatty liver, Biochemical and Biophysical Research Communications, 14, 1217, 10.1006/bbrc.1993.1546 · DOI
  23. Sparling, 1989, Analysis of membrane lipids by 500 MHz 1H NMR, Analytical Biochemistry, 178, 67, 10.1016/0003-2697(89)90358-8 · DOI
  24. Hugli, 1977, Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin, Proceedings of the National Academy of Sciences of the United States of America, 74, 1826, 10.1073/pnas.74.5.1826 · doi:10.1073/pnas.74.5.1826
  25. Klos, 2013, Complement peptide C5a, C4a, and C3a receptors, Pharmacological Reviews, 65, 500, 10.1124/pr.111.005223 · DOI · Paper page
  26. Litosch, 1982, Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes, Molecular Pharmacology, 22, 109, 10.1016/S0026-895X(25)14977-8 · DOI
  27. Schimmel, 1984, Stimulation of cAMP accumulation and lipolysis in hamster adipocytes with forskolin, American Journal of Physiology, 246, C63, 10.1152/ajpcell.1984.246.1.C63 · doi:10.1152/ajpcell.1984.246.1.c63
  28. Tavernier, 2005, Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice, Molecular Pharmacology, 68, 793, 10.1124/mol.105.014670 · DOI
  29. Chen, 2013, Identification of a receptor for neuropeptide VGF and its role in neuropathic pain, Journal of Biological Chemistry, 288, 34638, 10.1074/jbc.M113.510917 · DOI
  30. Norgauer, 1993, Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein, European Journal of Biochemistry, 217, 289, 10.1111/j.1432-1033.1993.tb18245.x · DOI
  31. Severini, 2008, TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation, Journal of Neurochemistry, 104, 534, 10.1111/j.1471-4159.2007.05068.x · DOI
  32. Petrocchi-Passeri, 2013, Neuropeptide TLQP-21, a VGF internal fragment, modulates hormonal gene expression and secretion in GH3 cell line, Neuroendocrinology, 97, 212, 10.1159/000339855 · doi:10.1159/000339855
  33. Petrocchi-Passeri, 2015, The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose homeostasis, Journal of Molecular Endocrinology, 54, 227, 10.1530/JME-14-0313 · doi:10.1530/jme-14-0313
  34. Agell, 2002, Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin, Cell Signal, 14, 649, 10.1016/S0898-6568(02)00007-4 · DOI · Paper page
  35. Cullen, 2002, Integration of calcium and Ras signaling, Nature Reviews Molecular Cell Biology, 3, 339, 10.1038/nrm808 · DOI · Paper page
  36. Chuderland, 2008, Calcium regulates ERK signaling by modulating its protein–protein interactions, Communicative & Integrative Biology, 1, 4, 10.4161/cib.1.1.6107 · DOI
  37. Greenberg, 2001, Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway, Journal of Biological Chemistry, 276, 45456, 10.1074/jbc.M104436200 · DOI · Paper page
  38. Arner, 1991, In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue, Journal of Pharmacology and Experimental Therapeutics, 259, 317, 10.1016/S0022-3565(25)20374-3 · DOI
  39. Guo, 1997, Regional lipolytic responses to isoproterenol in women, American Journal of Physiology, 273, E108
  40. Foglesong, 2016, Role of hypothalamic VGF in energy balance and metabolic adaption to environmental enrichment in mice, Endocrinology, 157, 983, 10.1210/en.2015-1627 · DOI
  41. Sadahiro, 2015, Role of VGF-derived carboxy-terminal peptides in energy balance and reproduction: analysis of “humanized” knockin mice expressing full-length or truncated VGF, Endocrinology, 156, 1724, 10.1210/en.2014-1826 · DOI
  42. Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nature Medicine, 18, 1575, 10.1038/nm.2897 · DOI · Paper page
  43. Yoneshiro, 2013, Recruited brown adipose tissue as an antiobesity agent in humans, Journal of Clinical Investigation, 123, 3404, 10.1172/JCI67803 · DOI · Paper page
  44. Severini, 2009, In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions, British Journal of Pharmacology, 157, 984, 10.1111/j.1476-5381.2009.00192.x · doi:10.1111/j.1476-5381.2009.00192.x
  45. Petrella, 2012, TLQP-21, a VGF-derived peptide, stimulates exocrine pancreatic secretion in the rat, Peptides, 36, 133, 10.1016/j.peptides.2012.03.035 · doi:10.1016/j.peptides.2012.03.035
  46. Damann, 2008, TRPs in our senses, Current Biology, 18, R880, 10.1016/j.cub.2008.07.063 · DOI · Paper page
  47. Sukumar, 2012, Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin, Circulation Research, 111, 191, 10.1161/CIRCRESAHA.112.270751 · DOI
  48. Ember, 1991, Designing synthetic superagonists of C3a anaphylatoxin, Biochemistry, 30, 3603, 10.1021/bi00229a003 · DOI
  49. Coulthard, 2015, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, Journal of Immunology, 194, 3542, 10.4049/jimmunol.1403068 · DOI · Paper page
  50. Lo, 2014, Adipsin is an adipokine that improves β cell function in diabetes, Cell, 158, 41, 10.1016/j.cell.2014.06.005 · DOI · Paper page
  51. Lim, 2013, C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling, FASEB Journal, 27, 822, 10.1096/fj.12-220582 · DOI · Paper page
  52. Hahm, 2002, VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting, Journal of Neuroscience, 22, 6929, 10.1523/JNEUROSCI.22-16-06929.2002 · DOI
  53. Hahm, 1999, Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance, Neuron, 23, 537, 10.1016/S0896-6273(00)80806-5 · DOI · Paper page
  54. Watson, 2005, VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity, Endocrinology, 146, 5151, 10.1210/en.2005-0588 · DOI
  55. Roy, 2008, Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet, American Journal of Physiology – Endocrinology and Metabolism, 294, E1051, 10.1152/ajpendo.00689.2007 · DOI
  56. Murray, 2000, Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein, Endocrinology, 141, 1041, 10.1210/endo.141.3.7364 · doi:10.1210/endo.141.3.7364
  57. Markiewski, 2007, The role of complement in inflammatory diseases from behind the scenes into the spotlight, American Journal of Pathology, 171, 715, 10.2353/ajpath.2007.070166 · DOI · Paper page
  58. Nettesheim, 1988, Secondary structure of complement component C3a anaphylatoxin in solution as determined by NMR spectroscopy: differences between crystal and solution conformations, Proceedings of the National Academy of Sciences of the United States of America, 85, 5036, 10.1073/pnas.85.14.5036 · DOI
  59. White, 1992, Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue, Journal of Biological Chemistry, 267, 9210, 10.1016/S0021-9258(19)50409-4 · DOI · Paper page
  60. Cianflone, 2003, Critical review of acylation-stimulating protein physiology in humans and rodents, Biochimica et Biophysica Acta, 1609, 127, 10.1016/S0005-2736(02)00686-7 · DOI · Paper page
  61. Murray, 1999, Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity, Biochemical Journal, 342, 41, 10.1042/bj3420041 · doi:10.1042/bj3420041
  62. Bradley, 2005, Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes, Obesity Research, 13, 653, 10.1038/oby.2005.73 · DOI
  63. Giordano, 2005, Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting, Journal of Histochemistry & Cytochemistry, 53, 679, 10.1369/jhc.4A6566.2005 · DOI

Cited by

Metadata

Authors
Cero, C., Razzoli, M., Han, R., Sahu, B. S., Patricelli, J., Guo, Z., Zaidman, N. A., Miles, J. M., O'Grady, S. M., & Bartolomucci, A.
Venue
Molecular Metabolism
Publisher
Elsevier BV
Published
2017-01
Volume
6
Issue
1
Pages
148-158
ISSN
2212-8778
Cited by
43
References
4
Language
en
Licence
Funders
  • NIH/NIDDK (R01 DK102496)
  • Decade of Discovery in Diabetes Grant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.